Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 2026 TeoTwawKi ... 2032 Darkest Interregnum -- Ignore unavailable to you. Want to Upgrade?

To: THE ANT who wrote (173435)	6/20/2021 7:50:00 PM
From: TobagoJack	Respond to of 217742

Thank you Ant. I think you are correct, that the risk of catching the disease, have it go symptomatic, and end up being severe, especially in the absence of near term intention to travel, is moderate The mRNA stuff is after all experimental as far as vaccine use concerned, and the symptomatic side-effects are rather dire even though so far % apparently / visibly affecting is (still) small, however the effects might be mostly below visible threshold (I guess, unless we open up apparently healthy people and see) and are cumulative until symptomatic as successive shots are taken over the coming seasons. The more traditional stuff seems to 'guarantee' no hospital visit and no fatality, and absent the blood clot issues Delaying taking the shot to extent practical seems obviously okay, gives the information flow a chance, seeing the controversy play out The vaccination script is certainly contentious. OTOH scmp.com Coronavirus: Hong Kong study finds ‘substantial’ antibody-level difference between BioNTech, Sinovac jab recipients - Amount of antibodies does not directly reflect individual’s level of protection, but researcher notes increasing evidence that higher levels generally correspond with greater immunity against infection - Objective of study was to estimate incidence of natural infections over time and level of population immunity due to infections and vaccinations OTOH scmp.com Coronavirus: Philippines signs deal for 40 million Pfizer shots; Singapore sees early rush for Sinovac vaccine - Deliveries of the Pfizer vaccine will begin ‘after eight weeks starting August’, Filipino vaccine tsar Carlito Galvez said - Elsewhere, Singapore private clinics are reporting overwhelming demand for the Sinovac shot, while India has recorded the lowest daily number of cases in nearly three months OTTH edition.cnn.com China has administered more than 1 billion Covid-19 vaccine doses and then there be ... bloomberg.com Seychelles’s Covid Mysteries Pit Anti-Vaxxers Against Scientists Cases in the world’s most vaccinated nation are ticking up, forcing researchers to wage war against misinformation on whether jabs are effective... ... What’s happening in Seychelles is very different from the experience of Israel, the second-most vaccinated nation, where Covid-19 infections have plummeted ... ... What’s also apparent, so far, is that though there’s been a surge in cases in Seychelles, very few people are getting seriously ill. “We have only a few people needing intensive care. Two out of 40” in hospitals, said Seychelles President Wavel Ramkalawan in a May 10 interview. “The vaccine will protect people from getting serious symptoms.” keweenawreport.com Israel says Pfizer vaccine probably causes myocarditis in young men